Bae Chu

Feasibility of Administering High‐Dose 131I–MIBG Therapy to Children with High‐Risk Neuroblastoma Without Lead‐Lined Rooms

L. Dauer, J. Carrasquillo, N. Pandit-Taskar, 2016, Pediatric blood & cancer.

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

J. Humm, S. Larson, M. Souweidane, 2022, Journal of Hematology & Oncology.

SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX

L. Dauer, M. Williamson, B. Quinn, 2022, Radiation protection dosimetry.

Radiological protection for pregnant women at a large academic medical Cancer Center.

L. Dauer, D. Miodownik, M. Williamson, 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Safety Reports Series No. 63, Release of Patients After Radionuclide Therapy

Bae Chu, 2013 .

Patient‐specific radiological protection precautions following Cs collagen embedded Cs‐131 implantation in the brain

G. Cohen, L. Dauer, K. Beal, 2022, Journal of applied clinical medical physics.

Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides

M. McDevitt, L. Dauer, N. Pandit-Taskar, 2021, The Journal of Nuclear Medicine Technology.